ORTOMA AB B (82Y) - Cash Flow Conversion Efficiency
Based on the latest financial reports, ORTOMA AB B (82Y) has a cash flow conversion efficiency ratio of -0.120x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-17.13 Million ≈ $-20.03 Million USD) by net assets (€142.72 Million ≈ $166.85 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see ORTOMA AB B market cap and net worth for the company's overall valuation and market capitalisation.
ORTOMA AB B - Cash Flow Conversion Efficiency Trend (2021–2025)
This chart illustrates how ORTOMA AB B's cash flow conversion efficiency has evolved over time, based on yearly financial data.
ORTOMA AB B Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of ORTOMA AB B ranked by their cash flow conversion efficiency. Explore ORTOMA AB B earnings quality ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Medico Remedies Limited
NSE:MEDICO
|
0.009x |
|
Aarey Drugs & Pharmaceuticals Limited
NSE:AAREYDRUGS
|
0.006x |
|
Maquia Capital Acquisition Corp
NASDAQ:MAQC
|
0.008x |
|
Century Lithium Corp.
V:LCE
|
-0.005x |
|
Jeil Steel Mfg Co. Ltd
KQ:023440
|
-0.047x |
|
Dusk Group Ltd
AU:DSK
|
-0.078x |
|
TDb Split Corp
TO:XTD
|
-0.045x |
|
MFS Investment Grade Municipal Trust
NYSE:CXH
|
0.023x |
Annual Cash Flow Conversion Efficiency for ORTOMA AB B (2021–2025)
The table below shows the annual cash flow conversion efficiency of ORTOMA AB B from 2021 to 2025. View 82Y share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €142.72 Million ≈ $166.85 Million |
€6.04 Million ≈ $7.06 Million |
0.042x | +131.12% |
| 2024-12-31 | €161.91 Million ≈ $189.29 Million |
€-22.01 Million ≈ $-25.73 Million |
-0.136x | -276.65% |
| 2023-12-31 | €173.54 Million ≈ $202.88 Million |
€13.35 Million ≈ $15.61 Million |
0.077x | +206.13% |
| 2022-12-31 | €114.29 Million ≈ $133.62 Million |
€-8.29 Million ≈ $-9.69 Million |
-0.073x | +37.94% |
| 2021-12-31 | €130.04 Million ≈ $152.03 Million |
€-15.19 Million ≈ $-17.76 Million |
-0.117x | -- |
About ORTOMA AB B
Ortoma AB (publ) provides orthopedic surgical products in Sweden. It offers Ortoma Treatment Solution (OTS), an orthopedic digital, server-based integrated AI platform designed to optimize patient outcomes through surgical planning, precision surgical navigation, post-operative verification, and follow-up; OTS Plan, a software that processes and assists surgeons during pre-operative planning and … Read more